After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
VNDA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Vanda Pharmaceuticals Inc is $224.98M. A total of 0.71 million shares were traded on the day, compared to an average of 984.09K shares.
In the most recent transaction, Polymeropoulos Mihael Hristos sold 24,288 shares of VNDA for 4.13 per share on Mar 05 ’24. After the transaction, the President and CEO now owns 1,871,730 company shares. In a previous transaction on Mar 05 ’24, Wijkstrom Joakim sold 9,229 shares at 4.21 per share. VNDA shares that SVP, Chief Marketing Officer owns now total 129,789.
Among the insiders who sold shares, Moran Kevin Patrick disposed of 8,902 shares on Mar 05 ’24 at a per-share price of $4.20. This resulted in the SVP, CFO & Treasurer holding 231,014 shares of VNDA after the transaction. In another insider transaction, Williams Timothy sold 8,941 shares at $4.18 per share on Mar 05 ’24. Company shares held by the SVP & General Counsel now total 196,825.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VNDA has a high of $7.00 and a low of $3.30.
As of this writing, VNDA has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of $0.05 per share and a lower estimate of $0.05. The company reported an EPS of $0 in the last quarter, which was 100.00% higher than expectations of -$0.04.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VNDA’s latest balance sheet shows that the firm has $432.81M in Cash & Short Term Investments as of fiscal 2021. There were $12.37M in debt and $74.42M in liabilities at the time. Its Book Value Per Share was $9.47, while its Total Shareholder’s Equity was $504.93M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VNDA is Buy with a score of 3.00.
